| 6.0 |
18.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 5.5 |
16.4 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 5.4 |
27.0 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 4.0 |
15.8 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 3.8 |
3.8 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 3.7 |
14.9 |
GO:0045608 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 3.6 |
10.9 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 3.3 |
23.4 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 3.0 |
9.0 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 3.0 |
9.0 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 2.8 |
2.8 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 2.8 |
8.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 2.7 |
8.2 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 2.6 |
7.8 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 2.5 |
2.5 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 2.4 |
7.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 2.4 |
7.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 2.3 |
11.7 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 2.2 |
11.1 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 2.2 |
6.5 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 2.2 |
10.8 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 2.1 |
8.6 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 2.1 |
2.1 |
GO:2000974 |
negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 2.1 |
10.6 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 2.1 |
2.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 2.1 |
6.2 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 2.0 |
63.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 2.0 |
6.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 2.0 |
12.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 2.0 |
44.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 2.0 |
6.0 |
GO:1905065 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 2.0 |
5.9 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 2.0 |
9.8 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 2.0 |
2.0 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 1.9 |
9.7 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 1.9 |
1.9 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.9 |
9.7 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 1.9 |
5.8 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 1.9 |
5.7 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.9 |
7.6 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.9 |
5.7 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.9 |
7.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 1.9 |
9.3 |
GO:0071038 |
nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 1.9 |
7.4 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.8 |
5.5 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 1.8 |
18.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.8 |
12.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.8 |
5.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 1.8 |
30.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 1.8 |
5.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 1.8 |
5.3 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.7 |
8.7 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 1.7 |
12.0 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 1.7 |
5.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.7 |
17.0 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 1.7 |
5.1 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.7 |
6.7 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 1.7 |
6.6 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 1.6 |
3.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.6 |
8.1 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 1.6 |
3.2 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.6 |
4.7 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 1.6 |
1.6 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 1.6 |
4.7 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.6 |
6.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.6 |
6.3 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.5 |
41.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 1.5 |
6.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.5 |
4.6 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 1.5 |
4.6 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 1.5 |
7.4 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 1.5 |
1.5 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 1.4 |
5.8 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 1.4 |
8.6 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 1.4 |
2.9 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.4 |
4.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.4 |
15.2 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 1.4 |
12.4 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 1.4 |
2.7 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 1.4 |
12.3 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 1.4 |
2.7 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 1.3 |
8.1 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 1.3 |
5.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.3 |
10.7 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 1.3 |
2.7 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.3 |
5.3 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 1.3 |
1.3 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 1.3 |
10.5 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 1.3 |
1.3 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 1.3 |
2.6 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 1.3 |
10.5 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 1.3 |
3.9 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.3 |
5.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.3 |
10.3 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 1.3 |
3.9 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 1.3 |
7.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.3 |
17.6 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 1.3 |
5.0 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 1.2 |
3.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 1.2 |
5.0 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 1.2 |
6.2 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 1.2 |
6.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 1.2 |
3.7 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.2 |
3.7 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 1.2 |
3.7 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.2 |
3.7 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 1.2 |
3.7 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 1.2 |
3.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 1.2 |
3.7 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 1.2 |
7.3 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 1.2 |
6.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.2 |
3.7 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.2 |
1.2 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.2 |
12.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 1.2 |
14.6 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 1.2 |
9.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 1.2 |
49.2 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 1.2 |
8.4 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 1.2 |
3.6 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 1.2 |
5.9 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 1.2 |
5.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 1.2 |
1.2 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 1.2 |
2.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.2 |
16.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 1.1 |
5.7 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 1.1 |
13.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 1.1 |
8.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 1.1 |
4.5 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 1.1 |
3.4 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.1 |
17.0 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 1.1 |
14.5 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 1.1 |
2.2 |
GO:1902074 |
response to salt(GO:1902074) |
| 1.1 |
4.5 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.1 |
12.2 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 1.1 |
8.9 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.1 |
6.6 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.1 |
3.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
| 1.1 |
1.1 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 1.1 |
4.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.1 |
4.3 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 1.1 |
4.3 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 1.1 |
4.3 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.1 |
6.3 |
GO:0032796 |
uropod organization(GO:0032796) |
| 1.1 |
2.1 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 1.0 |
2.1 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 1.0 |
4.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 1.0 |
10.4 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 1.0 |
2.1 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 1.0 |
7.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 1.0 |
6.1 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 1.0 |
4.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.0 |
8.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.0 |
3.0 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 1.0 |
1.0 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 1.0 |
5.0 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.0 |
6.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.0 |
4.0 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 1.0 |
3.0 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 1.0 |
6.9 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 1.0 |
10.7 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 1.0 |
3.9 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 1.0 |
1.9 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 1.0 |
2.9 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 1.0 |
1.9 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.0 |
6.7 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 1.0 |
3.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.0 |
4.8 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.0 |
2.9 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.0 |
1.9 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.9 |
4.7 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.9 |
1.9 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.9 |
2.8 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
| 0.9 |
2.8 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.9 |
6.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.9 |
7.3 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.9 |
3.7 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.9 |
0.9 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.9 |
9.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.9 |
1.8 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.9 |
2.7 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.9 |
0.9 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.9 |
1.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.9 |
10.7 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.9 |
3.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.9 |
6.2 |
GO:0045023 |
G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
| 0.9 |
7.9 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.9 |
3.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.9 |
2.6 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.9 |
5.3 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.9 |
3.5 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.9 |
2.6 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.9 |
43.1 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.9 |
5.2 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.9 |
5.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
2.6 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.9 |
2.6 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.9 |
2.6 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.9 |
1.7 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.9 |
2.6 |
GO:0070543 |
response to linoleic acid(GO:0070543) |
| 0.8 |
1.7 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.8 |
6.7 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.8 |
1.7 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.8 |
2.5 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.8 |
2.5 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.8 |
1.7 |
GO:0006901 |
vesicle coating(GO:0006901) |
| 0.8 |
1.7 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.8 |
2.5 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.8 |
0.8 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.8 |
6.5 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.8 |
7.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.8 |
5.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.8 |
2.4 |
GO:0007320 |
insemination(GO:0007320) |
| 0.8 |
5.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.8 |
5.6 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.8 |
2.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.8 |
4.8 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.8 |
8.0 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.8 |
4.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.8 |
1.6 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.8 |
7.9 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.8 |
1.6 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.8 |
7.8 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.8 |
2.3 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.8 |
5.4 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.8 |
2.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.8 |
1.5 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.8 |
1.5 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.8 |
25.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.8 |
2.3 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.8 |
3.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 |
2.3 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.8 |
2.3 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.8 |
2.3 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.8 |
3.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.8 |
1.5 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.8 |
1.5 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.7 |
1.5 |
GO:2000562 |
negative regulation of interferon-gamma secretion(GO:1902714) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.7 |
3.0 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 |
27.2 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.7 |
2.9 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.7 |
4.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.7 |
2.9 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.7 |
8.8 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.7 |
1.4 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.7 |
5.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.7 |
2.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 |
5.7 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.7 |
11.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.7 |
12.8 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.7 |
2.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.7 |
4.3 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.7 |
1.4 |
GO:1900158 |
regulation of chondrocyte development(GO:0061181) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.7 |
2.8 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.7 |
9.9 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.7 |
21.1 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.7 |
2.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.7 |
17.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.7 |
1.4 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.7 |
4.8 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.7 |
7.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.7 |
2.1 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.7 |
4.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.7 |
3.4 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.7 |
3.4 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.7 |
2.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.7 |
4.7 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.7 |
2.0 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.7 |
4.0 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.7 |
3.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.7 |
2.6 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.7 |
23.0 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.7 |
1.3 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.7 |
13.1 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.7 |
2.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.7 |
5.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.6 |
2.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.6 |
3.9 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.6 |
1.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.6 |
1.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.6 |
1.9 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.6 |
2.5 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.6 |
1.9 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.6 |
3.8 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.6 |
1.9 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.6 |
3.8 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.6 |
0.6 |
GO:2000786 |
positive regulation of vacuole organization(GO:0044090) positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 |
2.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.6 |
1.9 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.6 |
0.6 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.6 |
2.5 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 |
1.9 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.6 |
1.9 |
GO:0046533 |
regulation of photoreceptor cell differentiation(GO:0046532) negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.6 |
1.2 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.6 |
3.1 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.6 |
2.5 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.6 |
3.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.6 |
1.2 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.6 |
9.1 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.6 |
3.0 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.6 |
2.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.6 |
4.2 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.6 |
1.8 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.6 |
2.4 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.6 |
3.0 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.6 |
2.9 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.6 |
1.8 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.6 |
16.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.6 |
72.8 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.6 |
0.6 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.6 |
1.8 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.6 |
2.3 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.6 |
2.3 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.6 |
1.2 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.6 |
6.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.6 |
0.6 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.6 |
2.9 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.6 |
1.7 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.6 |
2.9 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.6 |
1.1 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.6 |
1.1 |
GO:0071224 |
detection of peptidoglycan(GO:0032499) cellular response to peptidoglycan(GO:0071224) |
| 0.6 |
1.7 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.6 |
8.4 |
GO:0061162 |
establishment of monopolar cell polarity(GO:0061162) |
| 0.6 |
2.8 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.6 |
2.8 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.6 |
1.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.6 |
3.9 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.5 |
3.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.5 |
2.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.5 |
13.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.5 |
0.5 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.5 |
1.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.5 |
0.5 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.5 |
2.7 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.5 |
1.6 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.5 |
1.6 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.5 |
1.6 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.5 |
1.1 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.5 |
2.7 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 |
2.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.5 |
4.3 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.5 |
9.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.5 |
1.6 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.5 |
1.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.5 |
1.6 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.5 |
10.4 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.5 |
2.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.5 |
4.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.5 |
2.6 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.5 |
0.5 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.5 |
2.6 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 |
1.0 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.5 |
1.5 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.5 |
0.5 |
GO:0006379 |
mRNA cleavage(GO:0006379) RNA phosphodiester bond hydrolysis(GO:0090501) |
| 0.5 |
2.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.5 |
2.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.5 |
2.5 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
2.5 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.5 |
4.5 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.5 |
2.5 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.5 |
1.5 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
1.5 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.5 |
6.5 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.5 |
1.0 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.5 |
1.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.5 |
3.0 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 |
1.0 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.5 |
5.9 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.5 |
2.0 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
9.8 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 |
3.9 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.5 |
11.2 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.5 |
1.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.5 |
4.3 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.5 |
1.0 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.5 |
5.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.5 |
1.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 |
1.4 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.5 |
5.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.5 |
2.4 |
GO:0031055 |
chromatin remodeling at centromere(GO:0031055) |
| 0.5 |
1.9 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.5 |
6.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.5 |
3.8 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.5 |
3.3 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.5 |
3.3 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.5 |
32.8 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.5 |
1.9 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.5 |
1.4 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 |
0.9 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.5 |
1.4 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.5 |
0.5 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
0.9 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 |
1.4 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.5 |
1.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.5 |
1.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.5 |
1.8 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 |
5.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.5 |
3.2 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.5 |
11.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.5 |
3.7 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.5 |
7.3 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.5 |
6.9 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.5 |
7.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.5 |
3.2 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.5 |
1.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.5 |
2.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.5 |
0.9 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.5 |
2.3 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.5 |
1.8 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.5 |
2.7 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.4 |
1.8 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.4 |
0.4 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.4 |
2.7 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.4 |
7.2 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.4 |
1.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.4 |
6.6 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.4 |
8.4 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.4 |
1.8 |
GO:0070384 |
trachea cartilage development(GO:0060534) Harderian gland development(GO:0070384) |
| 0.4 |
2.6 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.4 |
5.2 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.4 |
1.3 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.4 |
1.3 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.4 |
7.8 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.4 |
3.0 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.4 |
0.9 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.4 |
5.6 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.4 |
2.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.4 |
0.9 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 0.4 |
1.7 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.4 |
2.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 |
5.5 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.4 |
3.4 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.4 |
2.1 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.4 |
0.4 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.4 |
1.3 |
GO:0090220 |
telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.4 |
1.3 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.4 |
1.3 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.4 |
8.4 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.4 |
11.7 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.4 |
2.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.4 |
1.7 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 |
1.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 |
2.1 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.4 |
1.7 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.4 |
0.8 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.4 |
1.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 |
1.2 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.4 |
1.6 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.4 |
0.8 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
2.0 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.4 |
2.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.4 |
2.0 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 |
2.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.4 |
0.8 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.4 |
3.6 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.4 |
1.6 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.4 |
2.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
4.0 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.4 |
3.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
2.0 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.4 |
0.4 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.4 |
0.4 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.4 |
11.4 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.4 |
36.5 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.4 |
2.3 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.4 |
10.5 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.4 |
2.3 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.4 |
3.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
3.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
1.9 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.4 |
2.3 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.4 |
1.9 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.4 |
0.8 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.4 |
4.2 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 |
0.4 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.4 |
1.9 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 |
2.3 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.4 |
1.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.4 |
1.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.4 |
1.1 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 |
4.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 |
1.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.4 |
1.5 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.4 |
2.6 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.4 |
1.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.4 |
1.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.4 |
3.0 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.4 |
0.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
1.5 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
9.1 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.4 |
1.1 |
GO:0016068 |
regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
| 0.4 |
1.8 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.4 |
2.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.3 |
1.0 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
1.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
4.2 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.3 |
4.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.3 |
1.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
| 0.3 |
1.0 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.3 |
1.7 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 |
1.0 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
1.0 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.3 |
2.4 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.3 |
0.7 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.3 |
2.0 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.3 |
2.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 |
1.0 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.3 |
4.3 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
1.7 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.3 |
4.6 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.3 |
1.3 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.3 |
1.6 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.3 |
0.3 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.3 |
1.9 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.3 |
3.6 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
0.3 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.3 |
3.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.3 |
4.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.3 |
1.0 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 |
0.9 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.3 |
1.9 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
0.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.3 |
2.5 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
2.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.3 |
4.4 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.3 |
0.6 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.3 |
1.5 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.3 |
1.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.3 |
1.2 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.3 |
1.2 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
0.9 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 |
1.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
0.9 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.3 |
10.2 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.3 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.3 |
0.9 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.3 |
3.8 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.3 |
1.2 |
GO:0034644 |
cellular response to UV(GO:0034644) |
| 0.3 |
1.4 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.3 |
1.2 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.3 |
1.4 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.3 |
1.1 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.3 |
4.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 |
2.8 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.3 |
1.1 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.3 |
0.8 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.3 |
5.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.3 |
1.7 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.3 |
1.1 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.3 |
0.8 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.3 |
2.5 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.3 |
0.6 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.3 |
0.3 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 |
3.0 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 |
0.8 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
8.5 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.3 |
10.4 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
| 0.3 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
1.3 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.3 |
1.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.3 |
1.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
2.1 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.3 |
2.4 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.3 |
1.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 |
0.3 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.3 |
2.7 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.3 |
2.6 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.3 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
0.5 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
0.5 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.3 |
1.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 |
1.0 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.3 |
2.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.3 |
2.3 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.3 |
3.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.3 |
0.3 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.3 |
1.0 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 |
5.1 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.3 |
1.0 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.3 |
0.5 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.2 |
1.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
1.5 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 |
1.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.2 |
0.5 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
2.2 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
1.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.7 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 |
2.9 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
1.2 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.2 |
3.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 |
3.9 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 |
9.1 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.2 |
1.0 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
0.9 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.2 |
0.2 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
1.6 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
1.2 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.2 |
0.5 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.2 |
1.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.2 |
1.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
0.7 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
1.2 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.2 |
1.2 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.2 |
3.2 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 |
5.5 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 |
2.1 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
0.9 |
GO:0031665 |
regulation of hydrogen peroxide metabolic process(GO:0010310) negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
0.5 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.2 |
0.7 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
0.7 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 |
5.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
2.4 |
GO:0034311 |
diol metabolic process(GO:0034311) |
| 0.2 |
1.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.4 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 |
2.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
2.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
0.9 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.2 |
6.6 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.2 |
10.2 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.2 |
1.1 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.2 |
0.6 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 |
4.2 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.2 |
53.1 |
GO:0006412 |
translation(GO:0006412) |
| 0.2 |
5.3 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.2 |
0.2 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.2 |
0.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 |
1.2 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 |
0.6 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
0.4 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
4.0 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
1.8 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.2 |
1.6 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.8 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
0.8 |
GO:0044321 |
response to leptin(GO:0044321) |
| 0.2 |
0.8 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 |
2.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 |
0.6 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.2 |
4.8 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.2 |
1.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
0.8 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.2 |
3.2 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.2 |
1.3 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 |
1.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.4 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.2 |
1.5 |
GO:0033240 |
positive regulation of cellular amine metabolic process(GO:0033240) |
| 0.2 |
0.6 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 |
1.3 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 |
3.1 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.2 |
1.5 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.2 |
0.5 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
0.9 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.2 |
2.0 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.9 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.2 |
1.4 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
1.8 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
1.6 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.2 |
0.9 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.2 |
0.9 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
0.5 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.2 |
0.9 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.2 |
0.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
0.5 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
2.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
1.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
0.8 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.2 |
3.0 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.2 |
2.7 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.2 |
1.0 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
0.5 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 |
1.8 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.2 |
2.4 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.2 |
3.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.2 |
0.8 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.2 |
0.3 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.2 |
0.6 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.2 |
0.8 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.2 |
1.1 |
GO:0042053 |
regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
| 0.2 |
1.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.2 |
1.4 |
GO:0032594 |
protein transport within lipid bilayer(GO:0032594) |
| 0.2 |
2.3 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
2.9 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
7.6 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.2 |
1.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.6 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.2 |
2.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
1.5 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
1.3 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
1.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.7 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
1.0 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.1 |
0.3 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.1 |
0.4 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.1 |
0.7 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
1.0 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.7 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.1 |
0.6 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.6 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.4 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
| 0.1 |
0.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.5 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
1.6 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
7.3 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.8 |
GO:0010092 |
specification of organ identity(GO:0010092) |
| 0.1 |
0.4 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
8.9 |
GO:0006399 |
tRNA metabolic process(GO:0006399) |
| 0.1 |
0.5 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.1 |
0.9 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.9 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.1 |
5.3 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.6 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
1.0 |
GO:0006525 |
arginine metabolic process(GO:0006525) |
| 0.1 |
1.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.7 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 |
1.0 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 0.1 |
0.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
1.8 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.3 |
GO:0051934 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of neurotransmitter uptake(GO:0051582) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 |
1.6 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.2 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.3 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.1 |
0.9 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
0.8 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.8 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
0.2 |
GO:0044026 |
DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
| 0.1 |
1.4 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
2.4 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
1.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
1.1 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.1 |
1.9 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
2.8 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 |
2.3 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.1 |
0.5 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.9 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
0.4 |
GO:0071493 |
positive thymic T cell selection(GO:0045059) cellular response to UV-B(GO:0071493) |
| 0.1 |
1.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.1 |
0.4 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.8 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.3 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.4 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.9 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
2.5 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 |
1.1 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.1 |
0.5 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
1.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.2 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.1 |
2.5 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 |
1.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.5 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
1.1 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.1 |
0.4 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.4 |
GO:0009988 |
cell-cell recognition(GO:0009988) |
| 0.1 |
0.8 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 |
0.2 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
0.5 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.7 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
3.6 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
1.0 |
GO:0007595 |
lactation(GO:0007595) |
| 0.1 |
1.6 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.1 |
0.6 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.3 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.4 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
1.1 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.1 |
0.5 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.1 |
0.5 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.1 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.1 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.1 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.4 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.5 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
1.9 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.3 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.5 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
1.4 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.4 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.3 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 |
0.7 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.1 |
0.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.1 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) |
| 0.1 |
0.9 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.1 |
GO:0045910 |
negative regulation of DNA recombination(GO:0045910) |
| 0.1 |
0.1 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.1 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.1 |
0.3 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.1 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 |
0.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
1.6 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.3 |
GO:0006213 |
pyrimidine nucleoside metabolic process(GO:0006213) |
| 0.1 |
0.3 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
0.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
7.1 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.1 |
0.4 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 |
0.3 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.5 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.1 |
1.0 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.7 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.5 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
0.2 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.2 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 |
0.3 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.3 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.0 |
0.1 |
GO:2000618 |
regulation of histone H4-K16 acetylation(GO:2000618) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.9 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.1 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.5 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.2 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.0 |
0.2 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.0 |
0.2 |
GO:0060765 |
androgen receptor signaling pathway(GO:0030521) regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.2 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.0 |
0.2 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.1 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.0 |
0.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
1.0 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.0 |
0.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.5 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.6 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.0 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.0 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.2 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.0 |
0.2 |
GO:0032366 |
intracellular sterol transport(GO:0032366) |
| 0.0 |
0.2 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.1 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.0 |
0.1 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 |
0.4 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.2 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.4 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.1 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
0.1 |
GO:0021508 |
floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.0 |
0.0 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.0 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.0 |
0.0 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.1 |
GO:0042744 |
hydrogen peroxide metabolic process(GO:0042743) hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
